← Eichor
Study identifier: NCT05620940 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

Condition: Opioid Dependence · Alcohol Dependence · Multiple Sclerosis  ·  Sponsor: Inventage Lab., Inc.

PhasePhase 1
Planned participants40
Who can joinMale, 18 Years to 55 Years
Healthy volunteersYes

About this study

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

This description comes directly from the study's public registry record.

Talk to the study team

HyeRyeon Kim  ·  82-31-608-0514  ·  hr.kim@inventagelab.com

Heesun Kim  ·  82-31-608-0514  ·  flower@inventagelab.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nucleus NetworkHerston, Queensland, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05620940